跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NP-4
首页
药物
NP-4
NP-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NANOPARTICLE (NP)-ENHANCED EXPRESSION OF AQUAPORIN-4 CHANNELS AND WATER TRANSPORT IN HUMAN ASTROCYTES
申请人: US GOV SEC NAVY
优先权: 2023
EP
US
WO
3 件公开
Pentapeptide, engineering bacterium and application of pentapeptide to improvement of chemotaxis and nonyl phenol degradation capability of microorganisms
申请人: YELLOW RIVER CONSERVANCY TECHNICAL INST
优先权: 2024
CN
Molecular perovskite energetic material NP-1 and preparation method thereof
申请人: UNIV NORTH CHINA
优先权: 2024
CN
Monoclonal antibody for resisting novel bunyavirus NP protein as well as preparation method and application of monoclonal antibody
申请人: NANJING DRUM TOWER HOSPITAL
优先权: 2025
CN
Np-Tau217 specific antibody and application of np-Tau217 specific antibody in Alzheimer's disease auxiliary diagnosis kit
申请人: VAZYME MEDICAL CO LTD
优先权: 2026
CN
Purple MHC I dominant epitope peptide of ebola virus nucleoprotein, and coding gene and application thereof
申请人: UNIV PLA AIR FORCE MEDICAL
优先权: 2024
CN
CATIONICALLY-ENFRAMED HIGH DENSITY AROMATIC PEPTIDES
申请人: UNIV CITY NEW YORK RES FOUND
优先权: 2025
US
Methods of producing cobalt nanoparticles and hollow metal nanospheres
申请人: UNIV CALIFORNIA
优先权: 2018
US
2 件公开
药物
反馈